Meseret T Asfaw David L Holtzman Gene F Kwan Lawrence T Oyewusi Carole D Mitnick Kwonjune J Seung
10.21010/ajidv15i2S.5
Afr J Infect Dis
2021 Sep 1;15(2 Suppl):38-41.
bedaquiline delamanid drug resistant tuberculosis qt-interval prolongation
CC BY
https://pubmed.ncbi.nlm.nih.gov/34595385/
PMC8457348
34595385
INCIDENCE OF HIGH GRADE QTCF PROLONGATION AND ITS MANAGEMENT AMONG PATIENTS UNDERGOING TREATMENT FOR DRUG RESISTANT TUBERCULOSIS (DR-TB): CASE SERIES
2021